Background Persistent infection with high‐risk human papillomaviruses (hrHPV) types is
causally linked with the development of cervical precancer and cancer. HPV types 16 and …

Background Uptake of human papillomavirus (HPV) vaccine remains low in many countries,
although the bivalent and quadrivalent HPV vaccines given as a three‐dose schedule are …

Objective: The purpose of this study was to test Theory of Planned Behavior (TPB) constructs
in predicting human papillomavirus (HPV) vaccination behavioral intentions of vaccine …

Background Neisseria meningitidis serogroup B (MnB) is a leading cause of invasive
meningococcal disease in adolescents and young adults. A recombinant factor H binding …

Context Despite current recommendations, human papillomavirus vaccine uptake remains
low. A systematic review and meta-analysis assessed the effectiveness of interventions …

College-age men were recruited using Facebook™ advertisements (ads), as well as
traditional recruitment methods, for a randomized controlled trial to compare immunological …

Background A variety of intervention strategies to improve Human Papillomavirus (HPV)
vaccination rates in adults exist; however, they have shown varying efficacy and inconsistent …

Background Immunological differences between males and females in response to viral
vaccines are well known. This the first review to examine them for the Human Papilloma …

In addition to its well-known effects on bone metabolism, vitamin D is an immunomodulating
hormone. Serum vitamin D levels in males 18–25 years were measured at baseline, and …

Abstract Background The MenB-FHbp vaccine is licensed to prevent meningococcal
serogroup B disease on either a 2-dose (0, 6 months) or 3-dose (0, 1–2, 6 months) series …